Christopher Verity

3.5k total citations
36 papers, 2.0k citations indexed

About

Christopher Verity is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Christopher Verity has authored 36 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 15 papers in Pediatrics, Perinatology and Child Health and 9 papers in Molecular Biology. Recurrent topics in Christopher Verity's work include Epilepsy research and treatment (15 papers), Neonatal and fetal brain pathology (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Christopher Verity is often cited by papers focused on Epilepsy research and treatment (15 papers), Neonatal and fetal brain pathology (10 papers) and Pharmacological Effects and Toxicity Studies (10 papers). Christopher Verity collaborates with scholars based in United Kingdom, Australia and New Zealand. Christopher Verity's co-authors include Richard Newton, Andrew Lux, Stuart W. Edwards, Colin Kennedy, Anthony L. Johnson, Eleanor Hancock, John Osborne, Finbar O’Callaghan, Jean Golding and Rosemary Greenwood and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Christopher Verity

35 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Verity United Kingdom 21 1.3k 960 340 269 269 36 2.0k
Andrew Lux United Kingdom 21 1.5k 1.2× 1.1k 1.2× 442 1.3× 285 1.1× 449 1.7× 43 2.5k
Tae‐Sung Ko South Korea 24 999 0.8× 597 0.6× 232 0.7× 216 0.8× 219 0.8× 116 1.7k
William Whitehouse United Kingdom 30 1.2k 1.0× 840 0.9× 374 1.1× 549 2.0× 160 0.6× 135 3.1k
Ignacio Valencia United States 27 988 0.8× 685 0.7× 186 0.5× 199 0.7× 278 1.0× 84 1.8k
Raffaele Falsaperla Italy 28 705 0.5× 728 0.8× 512 1.5× 645 2.4× 241 0.9× 277 2.8k
Nathan Watemberg Israel 28 780 0.6× 704 0.7× 208 0.6× 310 1.2× 119 0.4× 91 2.2k
Hasan Tekgül Türkiye 23 823 0.6× 926 1.0× 153 0.5× 190 0.7× 110 0.4× 119 1.8k
Edda Haberlandt Austria 25 641 0.5× 477 0.5× 288 0.8× 371 1.4× 187 0.7× 89 1.7k
Wendy G. Mitchell United States 37 2.0k 1.5× 1.5k 1.6× 358 1.1× 276 1.0× 165 0.6× 97 3.6k
Tamiko Negoro Japan 26 1.5k 1.1× 958 1.0× 276 0.8× 263 1.0× 103 0.4× 143 2.2k

Countries citing papers authored by Christopher Verity

Since Specialization
Citations

This map shows the geographic impact of Christopher Verity's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Verity with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Verity more than expected).

Fields of papers citing papers by Christopher Verity

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Verity. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Verity. The network helps show where Christopher Verity may publish in the future.

Co-authorship network of co-authors of Christopher Verity

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Verity. A scholar is included among the top collaborators of Christopher Verity based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Verity. Christopher Verity is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verity, Christopher, et al.. (2025). Variant Creutzfeldt-Jakob disease in UK children after 27 years of active prospective surveillance. Archives of Disease in Childhood. 110(6). 450–454. 1 indexed citations
2.
Osborne, John, Stuart W. Edwards, Fabienne Dietrich Alber, et al.. (2022). Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials. European Journal of Paediatric Neurology. 42. 110–116. 4 indexed citations
3.
Pennington, Mark, Jennifer Summers, Saskia Eddy, et al.. (2020). Selective dorsal rhizotomy; evidence on cost-effectiveness from England. PLoS ONE. 15(8). e0236783–e0236783. 3 indexed citations
4.
Verity, Christopher, Anne Marie Winstone, Robert Will, et al.. (2018). Surveillance for variant CJD: should more children with neurodegenerative diseases have autopsies?. Archives of Disease in Childhood. 104(4). 360–365. 6 indexed citations
5.
Verity, Christopher, L Stellitano, Anne Marie Winstone, et al.. (2014). Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barre syndrome. Archives of Disease in Childhood. 99(6). 532–538. 15 indexed citations
6.
O’Callaghan, Finbar, Andrew Lux, Stuart W. Edwards, et al.. (2011). The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: Evidence from the United Kingdom Infantile Spasms Study. Epilepsia. 52(7). 1359–1364. 215 indexed citations
7.
Ward, Katherine N., et al.. (2011). Herpes simplex serious neurological disease in young children: incidence and long-term outcome. Archives of Disease in Childhood. 97(2). 162–165. 35 indexed citations
8.
Smith, Nicholas, Anne Marie Winstone, L Stellitano, Timothy M. Cox, & Christopher Verity. (2011). GM2 gangliosidosis in a UK study of children with progressive neurodegeneration: 73 cases reviewed. Developmental Medicine & Child Neurology. 54(2). 176–182. 49 indexed citations
9.
Osborne, John, Andrew Lux, Stuart W. Edwards, et al.. (2010). The underlying etiology of infantile spasms (West syndrome): Information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification2. Epilepsia. 51(10). 2168–2174. 173 indexed citations
10.
Verity, Christopher, et al.. (2009). The clinical presentation of mitochondrial diseases in children with progressive intellectual and neurological deterioration: a national, prospective, population‐based study. Developmental Medicine & Child Neurology. 52(5). 434–440. 29 indexed citations
11.
Verity, Christopher, et al.. (2009). The epidemiology of progressive intellectual and neurological deterioration in childhood. Archives of Disease in Childhood. 95(5). 361–364. 49 indexed citations
12.
Archer, Hayley, Julie Evans, David Millar, et al.. (2006). NTNG1 mutations are a rare cause of Rett syndrome. American Journal of Medical Genetics Part A. 140A(7). 691–694. 38 indexed citations
13.
Lux, Andrew, Stuart W. Edwards, Eleanor Hancock, et al.. (2005). The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. The Lancet Neurology. 4(11). 712–717. 287 indexed citations
14.
Edwards, Stuart W., Eleanor Hancock, A. L. Johnson, et al.. (2004). The United Kingdom Infantile Spasm Study (UKISS) comparing vigabatrin with prednisolone or tetracosactride in West Syndrome in a randomised trial: the control of infantile spasms at 14 days. The Lancet. 1773–1778. 1 indexed citations
15.
Lux, Andrew, Stuart W. Edwards, Eleanor Hancock, et al.. (2004). The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. The Lancet. 364(9447). 1773–1778. 263 indexed citations
16.
Verity, Christopher. (2002). Surveillance for rare disorders by the BPSU. Archives of Disease in Childhood. 87(4). 269–271. 35 indexed citations
17.
Verity, Christopher. (1998). Do seizures damage the brain? The epidemiological evidence. Archives of Disease in Childhood. 78(1). 78–84. 42 indexed citations
18.
Easter, D. J., C. Gillies O'Bryan-Tear, & Christopher Verity. (1997). Weight gain with valproate or carbamazepine— a reappraisal. Seizure. 6(2). 121–125. 43 indexed citations
19.
Verity, Christopher. (1988). When to start anticonvulsant treatment in childhood epilepsy: the case for early treatment.. BMJ. 297(6662). 1528–1530. 4 indexed citations
20.
Verity, Christopher, et al.. (1983). The influence of anticonvulsants on fasting plasma ammonia and amino acid levels. Clinical Biochemistry. 16(6). 344–345. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Lux Breakdown of academic impact, for papers by Tae‐Sung Ko Breakdown of academic impact, for papers by William Whitehouse Breakdown of academic impact, for papers by Ignacio Valencia Breakdown of academic impact, for papers by Raffaele Falsaperla Breakdown of academic impact, for papers by Nathan Watemberg Breakdown of academic impact, for papers by Hasan Tekgül Breakdown of academic impact, for papers by Edda Haberlandt Breakdown of academic impact, for papers by Wendy G. Mitchell Breakdown of academic impact, for papers by Tamiko Negoro
Rankless by CCL
2026